SOLUTION STRUCTURE OF THE SUPERACTIVE MONOMERIC DES-[PHE(B25)] HUMAN INSULIN MUTANT. ELUCIDATION OF THE STRUCTURAL BASIS FOR THE MONOMERIZATION OF THE DES-[PHE(B25)] INSULIN AND THE DIMERIZATION OF NATIVE INSULIN
THR B 26 - PRO B 27 MODEL 19 OMEGA = 211.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
Solution structure of the superactive monomeric des-[Phe(B25)] human insulin mutant: elucidation of the structural basis for the monomerization of des-[Phe(B25)] insulin and the dimerization of native insulin.
A Carbon-13 NMR Study of the B9(Asp) Mutant of Human Insulin
Structural Details of Asp(B9) Human Insulin at Low Ph from 2D NMR Titration Studies
A New Linear Prediction Model Method for the Determination of Slow Amide Proton Exchange Rates from a Series of One-Dimensional 1H NMR Spectra
Slow Amide Proton Exchange Rates from the Line Widths in a Single Two-Dimensional 1H NMR Spectrum
Three-Dimensional Solution Structure of an Insulin Dimer. A Study of the B9(Asp) Mutant of Human Insulin Using Nuclear Magnetic Resonance Distance Geometry and Restrained Molecular Dynamics
Proton Nuclear Magnetic Resonance Study of the B9(Asp) Mutant of Human Insulin. Sequential Assignment and Secondary Structure